DEXMDERM Trademark

Trademark Overview

On Wednesday, February 15, 2023, a trademark application was filed for DEXMDERM with the United States Patent and Trademark Office. The USPTO has given the DEXMDERM trademark a serial number of 97796101. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, October 17, 2024. This trademark is owned by Teikoku Pharma USA, Inc.. The DEXMDERM trademark is filed in the Pharmaceutical Products category with the following description:

Transdermal patches for use in the management of pain; pharmaceutical topical preparations for use in the management of pain
dexmderm

General Information

Serial Number97796101
Word MarkDEXMDERM
Filing DateWednesday, February 15, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements

Goods and ServicesTransdermal patches for use in the management of pain; pharmaceutical topical preparations for use in the management of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeikoku Pharma USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95131
Party NameTeikoku Pharma USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95131

Trademark Events

Event DateEvent Description
Saturday, February 18, 2023NEW APPLICATION ENTERED
Tuesday, February 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 14, 2023ASSIGNED TO EXAMINER
Wednesday, November 15, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 15, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 9, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, February 9, 2024EXAMINERS AMENDMENT E-MAILED
Friday, February 9, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 9, 2024EXAMINER'S AMENDMENT ENTERED
Friday, February 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 17, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU EXTENSION 1 FILED
Thursday, October 17, 2024SOU EXTENSION 1 GRANTED

Related Keywords

dexmderm management pain preparations topical pharmaceutical transdermal patches